As investors look at their portfolios, foreign diversification is growing in prominence as a theme to watch. Domestic risks — including a higher-for-longer rate regime, the potential impact of tariffs, and stubborn inflation — loom over domestic-heavy U.S. portfolios. Perhaps most significant, however, is the concentration risk that emerged in 2024. Together, that may see some investors looking to diversify, with quality international equities marrying key themes in a fund like QINT.
See more: 3 Ways to Add ETF Diversification in 2025
The American Century Quality Diversified International ETF (QINT ) has performed very well over the last month. The quality international equities ETF has returned 9.37% YTD, per YCharts, as of February 19. That has outperformed the MSCI ACWI Ex USA Net Total Return Index YTD, according to YCharts. What’s more, that performance also helped QINT beat its ETF Database Category and FactSet Segment averages over one month, per ETF Database data.
Charging 39 basis points, QINT tracks the American Century Quality Diversified International Equity Index. The strategy’s index includes large- and midcap names exhibiting sound growth prospects as well as healthy financials. The strategy’s index leads it to hold a narrower portfolio, perhaps, than similar passive funds. That owes to its quality screen, looking for well-positioned, often larger firms. Its index moves between growth and value views depending on market conditions, as well.
What kind of firms does the quality international equities ETF invest in, then, with that approach? QINT currently holds major names like Sanofi (SNY). SNY, a pharmaceuticals firm, develops and markets drugs in areas like oncology, immunology, diabetes treatment, and more, per YCharts. QINT also allocates to other areas, like energy, via firms like Shell (SHELL). Together, the strategy’s approach could make it a worthwhile add in a satellite portfolio role, to diversify portfolios away from domestic risk.
VettaFi LLC (“VettaFi”) is the index provider for QINT, for which it receives an index licensing fee. However, QINT is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of QINT.
For more news, information, and analysis, visit the Core Strategies Channel.
